MICROBIOTEC SRL - Italy 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 2.701.874 261.500 1
2016 0 8.553.750 485.000 1
2012 0 5.818.937 646.549 1
2011 0 29.980.670 202.800 1
2010 0 11.999.998 198.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITA DEGLI STUDI DI SIENA5
COMMISSARIAT A L'ENERGIE ATOMIQUE3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
KING'S COLLEGE LONDON3
SCLAVO VACCINES ASSOCIATION3
UNIVERSITE DE GENEVE3
UNIVERSITEIT UTRECHT3
ABERA BIOSCIENCE AB2
ACADEMISCH ZIEKENHUIS LEIDEN2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
GOETEBORGS UNIVERSITET2
HOOKIPA BIOTECH2
MINERVA CONSULTING & COMMUNICATION2
PARTICLE SCIENCES INC2
ST GEORGE'S HOSPITAL MEDICAL SCHOOL2
STATENS SERUM INSTITUT2
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
ARENAVAX1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES1
BIONEEDLE TECHNOLOGIES GROUP BV1
CENTRE DE RECHERCHES MEDICALES DE LAMBARENE1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH1
CROSSBETA BIOSCIENCES BV1
DEPARTMENT OF HEALTH1
DUOTOL AB1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
EIDGENOSSISCHES DEPARTEMENT FUR VERTEIDIGUNG BEVOLKERUNGSSCHUTZ UND SPORT1
EMORY UNIVERSITY NON PROFIT CORP1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EUROPEAN AIDS TREATMENT GROUP EV1
FONDATION MINTAKA POUR LA RECHERCHE MEDICALE1
FONDAZIONE HUMANITAS PER LA RICERCA1
FONDAZIONE PER L'ISTITUTO DI RICERC A IN BIOMEDICINA1
GILEAD SCIENCES INC1
GLAXOSMITHKLINE BIOLOGICALS1
GLAXOSMITHKLINE VACCINES1
GSK VACCINES INSTITUTE FOR GLOBAL HEALTH1
HEALTH PROTECTION AGENCY1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
INFECTIOUS DISEASE RESEARCH INSTITUTE1
INSTITUT PASTEUR1
INSTITUTO DE SALUD CARLOS III1
INTERCELL1
INTERNATIONAL PARTNERSHIP FOR MICROBICIDES INC1
ISLENSK ERFDAGREINING EHF1
ISTITUTO SUPERIORE DI SANITA1
JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA JANSSEN INFECTIOUS DISEASES BVBA JANSSEN DIAGNOSTICS BVBA1
KAROLINSKA INSTITUTE1
KATHOLIEKE UNIVERSITEIT LEUVEN1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDICINE IN NEED FRANCE ASSOCIATION1
MEDITOX SRO1
MERCK SHARP & DOHME CORP1
MIDDLESEX UNIVERSITY1
OESTERREICHISCHE AKADEMIE DER WISSENSCHAFTEN1
PEVION BIOTECH1
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG1
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE1
REITHERA1
SEATTLE BIOMEDICAL RESEARCH INSTITUTE NON PROFIT CORPORATION1
SIGMOID PHARMA LIMITED1
SPOLUKA CHEMICAL COMPANY1
STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT1
STICHTING TUBERCULOSIS VACCINE INITIATIVE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE QUEEN'S UNIVERSITY OF BELFAST1
THE UNIVERSITY OF LIVERPOOL1
UNIVERSIDADE DE SAO PAULO1
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA1
UNIVERSITAET BASEL1
UNIVERSITAET INNSBRUCK1
UNIVERSITAT BASEL1
UNIVERSITEIT ANTWERPEN1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF ABERDEEN1
UNIVERSITY OF SURREY1
UNIVERSITY OF YORK1
VACCIBODY AS1
VALNEVA AUSTRIA1
VALNEVA SE1
VISMEDERI1
WORLD HEALTH ORGANIZATION1
XBRANE BIOSCIENCE AB1

Constancy:

Total number of partners: 109
Partner loyalty:
Frequent Partner: (> 2 projects): 23
Rare Partner: 86
Frequent / Rare Partner Ratio: 0.27

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01Novel vaccine vectors to resist pathogen challenge VacPathparticipant2.701.8748
2016-04-01SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068 VSV-EBOPLUSparticipant8.553.75011
2012-10-01Microbicide Optimization Through Innovative Formulation for Vaginal and Rectal Delivery MOTIFparticipant5.818.9379
2011-10-01Advanced Immunization Technologies ADITECparticipant29.980.67052
2010-01-01Combined Highly Active Anti-retroviral Microbicides CHAARMparticipant11.999.99834